Patent 12122824

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-flash

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

1 active
  • IPR2026-00258IPRfiled Mar 20, 2026vs. Accord BioPharma, Inc. et al.Pending

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (2)

Group view →

Specific litigation cases in our database that name US patent 12122824. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

Known litigation involving US patent 12122824 includes the following:

  1. District Court Litigation

    • Plaintiff(s): Janssen (and by inference, Centocor Biologic LLC, as the case filer)
    • Defendant(s): Implied to be Bio-Thera and potentially other unnamed parties, in the context of an aBLA for BAT2506.
    • Jurisdiction: U.S. District Court for the District of Delaware
    • Case Number: 1:26-cv-00222
    • Filing Date: February 27, 2026
    • Outcome/Current Status: Active / Ongoing. The case involves a declaratory judgment of infringement of U.S. Patent No. 12,122,824.

  2. PTAB Inter Partes Review (IPR)

    • Plaintiff(s) (Petitioner): Not explicitly named in available search snippets.
    • Defendant(s) (Patent Owner/Respondent): Janssen Biotech Inc. (as the current assignee of the patent).
    • Jurisdiction: Patent Trial and Appeal Board (PTAB)
    • Case Number: IPR2026-00258
    • Filing Date: March 27, 2026
    • Outcome/Current Status: Pending

Generated 5/29/2026, 5:52:34 PM